Advanced Filters
noise

Parkinson's Disease Clinical Trials

A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 590 clinical trials
Z Zhao Guohua, Doctor

Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease

To evaluate the efficacy and safety of tenofovir disoproxil fumarate in the treatment of Parkinson's disease. The changes of motor symptoms and the occurrence of adverse reactions in early Parkinson's disease patients who took tenofovir disoproxil fumarate and did not take Tenofovir disoproxil fumarate at different time points were compared.

18 - 65 years of age All Phase 1
Z Zhiquan Yang, MD, PhD

Evaluation of GM101 Injection in Patients With Parkinson's Disease

The objective of this study is to assess the safety of GM101 in participants with Parkinson's disease (PD)

40 - 70 years of age All Phase N/A
E Elizabeth A Jansen, MPH

Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial

The proposed multi-site, Genetics and Aerobic Exercise to Slow PD (GEARS) Trial will, for the first time, determine the interplay between genetics and exercise in altering PD progression. In sum, 200 PD patients will be recruited from the Cleveland and Salt Lake City metro areas to participate in the Pedaling …

18 years of age All Phase N/A
F Fabio Laporta

Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna

Parkinson's disease (PD) affects over 10 million worldwide, causing unstable gait and falls in 70% of patients despite medication. This leads to confidence loss, isolation, fractures, and hospitalizations. Treadmill training, augmented by mechanical/virtual-reality triggers, has proven effective in enhancing gait and reducing falls. However, underlying treadmill training mechanisms are unclear. …

years of age All Phase N/A
J Jacob Earp, MS

Daily Amino Acid Supplementation for People With Parkinson's Disease

The goal of this clinical trial is to learn if a tailored amino acid supplement works to help adults living with Parkinson's disease to improve nutrition, metabolic function, body composition, and physical and mental function. The main questions it aims to answer are: Does the tailored amino acid supplement increase …

60 - 80 years of age All Phase N/A

Movement Improves Brain Health and Cognition in Parkinson's Disease

Cognitive impairment is an acknowledged feature of Parkinson's disease (PD) and often coexists with the classic motor symptoms since their onset. Cognitive symptoms of PD can be differentiated from other neurodegenerative diseases by the affected domains: typically, the executive functions are primarily affected, to a greater extent than the mnesic …

30 - 80 years of age All Phase N/A
M Mohammed h Abouelsoud

Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms

This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to the scalp using small electrodes placed on the head. Participants will use the device at home for 13 minutes each weekday …

18 - 80 years of age All Phase 1/2
E Ethics Committee of the Shanghai University of Sport

Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease

The goal of this clinical trial is to learn whether a type of brain stimulation called transcranial temporal interference stimulation (TIS) of the internal globus pallidus (GPi) can help improve movement symptoms in people with Parkinson's disease. The study will also look at how TIS changes brain activity related to …

50 - 80 years of age All Phase N/A
R Research Coordinator

Sustained Release Oral Formulation for Treatment of Parkinson's Disease

Achieving sustained blood levels of carbidopa/levodopa has been a challenge in the treatment of PD and although levodopa remains the most commonly used drug, motor fluctuations remain a major disability especially in advanced Parkinson's disease. The aim of this study is to determine the efficacy of a novel oral carbidopa-levodopa …

18 - 65 years of age All Phase N/A
J Julius Welzel

Steps Against the Burden of Parkinson's Disease - RCT Kiel

Parkinson's disease (PD) affects over 10 million worldwide, causing unstable gait and falls in 70% of patients despite medication. This leads to confidence loss, isolation, fractures, and hospitalizations. Treadmill training, augmented by mechanical/virtual-reality triggers, has proven effective in enhancing gait and reducing falls. However, underlying treadmill training mechanisms are unclear. …

years of age All Phase N/A

Simplify language using AI